Jaguar Health Issues Pre-Funded Warrants in Exchange for Preferred Stock
I'm PortAI, I can summarize articles.
Jaguar Health Inc. has issued pre-funded warrants to purchase common stock in exchange for the cancellation of Series M Preferred Stock held by Iliad Research and Trading, L.P. The warrants allow for immediate exercise at $0.001 per share, with a 9.99% beneficial ownership cap. This transaction was exempt from registration under Section 3(a)(9) of the Securities Act of 1933.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments